RxDoctor Payments Data

Douglas Hage

Obstetrics & Gynecology · Derby, NYNPI 1538113873

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.4% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,430 and has fallen 64.5% since, to $508 in 2024. Among obstetrics & gynecology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,520in general payments, 2019–2025

Across 292 payments — averaging $18.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$791
  • Avion Pharmaceuticals$464
  • Astellas Pharma US Inc$436
  • Therapeuticsmd, Inc.$380
  • Agile Therapeutics, Inc.$317
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$5,26895%
  • Education$2525%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,520 in reported general payments places this provider in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.

See all obstetrics & gynecology providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated16$7,515
Estradiol57$3,675
ProgesteroneProgesterone, Micronized11$514
Oxybutynin Chloride ErOxybutynin Chloride12$257
Fluoxetine Hcl11$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$791$7,51516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,673 obstetrics & gynecology providers in New York.

Other obstetrics & gynecology in Derby

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →